Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
BioShin
company
About
BioShin is a clinical stage biopharmaceutical company.
- Shanghai,Shanghai,China
- 1 - 10
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $60M
- Industries
- Biotechnology,Health Care,Life Science,Pharmaceutical
- Founded date
- Jan 1, 2013
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Legal Name
- BioShin Ltd.
BioShin is a wholly owned subsidiary of Biohaven Pharmaceuticals, a public biotech company. BioShin is a clinical stage biopharmaceutical company focused on developing medicines. It has proven leadership from global industry and academic settings and a portfolio of innovative, late stage product candidates targeting neurological and neuropsychiatric diseases, including rare disorders.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$60M
BioShin has raised a total of
$60M
in funding over 2 rounds. Their latest funding was raised on
Sep 28, 2020 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 28, 2020 | Series A | $60M | 5 |
OrbiMed
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
5
BioShin is funded by 5 investors.
OrbiMed
and Cormorant Asset Management
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
OrbiMed
|
Yes | Series A |
Cormorant Asset Management
|
— | Series A |
HBM Healthcare Investments AG
|
— | Series A |
Surveyor Capital
|
— | Series A |
Suvretta Capital Management
|
— | Series A |
Employee Profiles
Number of Employee Profiles
4
BioShin has 4 current employee profiles, including
Board member David Wang
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
